MILFORD, Mass., May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise ...

Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional ...

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (WAT:NYSE) today introduced new size exclusion chromatography (SEC) columns for the characterization of proteins. For use with Waters ® Alliance ® ...

Biomanufacturers face the ongoing challenge of balancing costs and production timelines, with product quality and purity. Join us for this insightful webinar to explore the latest innovations for ...

In recent years, monoclonal antibodies (mAbs) have become one of the major biopharma products in response to the need to treat various diseases. These antibodies have been engineered with a specific ...